Decoy Therapeutics Inc. — Form 8-K
Filed July 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Form 8-K filed 2026-07-15 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) for period ending 2026-07-14. The filing document itself contains no disclosure of vote results, counterparties, dollar amounts, percentages, share counts, or specific matters voted upon—only the bare EDGAR metadata and filing headers are visible in the provided text.
Why this rating
Routine 8-K procedural filing. No substantive business event disclosed in provided text; standard SEC compliance submission for a micro-cap firm.
Extracted items
See more from July 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.